Source:http://linkedlifedata.com/resource/pubmed/id/20691660
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-9-6
|
pubmed:abstractText |
A novel nucleic acid analogue (2Cl-C.OXT-A) significantly stimulated tube formation of human umbilical endothelial cells (HUVEC). Its maximum potency at 100muM was stronger than that of vascular endothelial growth factor (VEGF), a positive control. At this concentration, 2Cl-C.OXT-A moderately stimulated proliferation as well as migration of HUVEC. To gain mechanistic insights how 2Cl-C.OXT-A promotes angiogenic responses in HUVEC, we performed immunoblot analyses using phospho-specific antibodies as probes. 2Cl-C.OXT-A induced robust phosphorylation/activation of MAP kinase ERK1/2 and an upstream MAP kinase kinase MEK. Conversely, a MEK inhibitor PD98059 abolished ERK1/2 activation and tube formation both enhanced by 2Cl-C.OXT-A. In contrast, MAP kinase responses elicited by 2Cl-C.OXT-A were not inhibited by SU5416, a specific inhibitor of VEGF receptor tyrosine kinase. Collectively these results suggest that 2Cl-C.OXT-A-induces angiogenic responses in HUVEC mediated by a MAP kinase cascade comprising MEK and ERK1/2, but independently of VEGF receptor tyrosine kinase. In vivo assay using chicken chorioallantoic membrane (CAM) and rabbit cornea also suggested the angiogenic potency of 2Cl-C.OXT-A.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1090-2104
|
pubmed:author |
pubmed-author:AshinoHiromiH,
pubmed-author:HattoriKenichiK,
pubmed-author:IgarashiJunsukeJ,
pubmed-author:KawataMitsuhiroM,
pubmed-author:KonishiRyojiR,
pubmed-author:KosakaHiroakiH,
pubmed-author:KubotaYasuoY,
pubmed-author:MaruyamaTokumiT,
pubmed-author:SakakibaraNorikazuN,
pubmed-author:TanakaShinjiS,
pubmed-author:TokudaMasaakiM,
pubmed-author:TsukamotoIkukoI
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
399
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
699-704
|
pubmed:meshHeading |
pubmed-meshheading:20691660-Adenosine,
pubmed-meshheading:20691660-Angiogenesis Inducing Agents,
pubmed-meshheading:20691660-Animals,
pubmed-meshheading:20691660-Cells, Cultured,
pubmed-meshheading:20691660-Endothelial Cells,
pubmed-meshheading:20691660-Humans,
pubmed-meshheading:20691660-Neovascularization, Physiologic,
pubmed-meshheading:20691660-Nucleic Acids,
pubmed-meshheading:20691660-Rabbits
|
pubmed:year |
2010
|
pubmed:articleTitle |
A novel nucleic acid analogue shows strong angiogenic activity.
|
pubmed:affiliation |
Department of Pharmaco-Bio-Informatics, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan. tukamoto@med.kagawa-u.ac.jp
|
pubmed:publicationType |
Journal Article
|